Combination of SAHA and bortezomib up-regulates CDKN2A and CDKN1A and induces apoptosis of Epstein-Barr virus-positive Wp-restricted Burkitt lymphoma and lymphoblastoid cell lines
- PMID: 25155625
- DOI: 10.1111/bjh.13089
Combination of SAHA and bortezomib up-regulates CDKN2A and CDKN1A and induces apoptosis of Epstein-Barr virus-positive Wp-restricted Burkitt lymphoma and lymphoblastoid cell lines
Abstract
Epstein-Barr virus (EBV) latent proteins exert anti-apoptotic effects on EBV-transformed lymphoid cells by down-regulating BCL2L11 (BIM), CDKN2A (p16(INK4A) ) and CDKN1A (p21(WAF1) ). However, the potential therapeutic effects of targeting these anti-apoptotic mechanisms remain unexplored. Here, we tested both in vitro and in vivo effects of the combination of histone deacetylase (HDAC) and proteasome inhibitors on the apoptosis of six endemic Burkitt lymphoma (BL) lines of different latency patterns (types I and III and Wp-restricted) and three lymphoblastoid cell lines (LCLs). We found that the combination of HDAC and proteasome inhibitors (e.g. SAHA/bortezomib) synergistically induced the killing of Wp-restricted and latency III BL and LCLs but not latency I BL cells. The synergistic killing was due to apoptosis, as evidenced by the high percentage of annexin V positivity and strong cleavage of PARP1 (PARP) and CASP3 (caspase-3). Concomitantly, SAHA/bortezomib up-regulated the expression of CDKN2A and CDKN1A but did not affect the level of BCL2L11 or BHRF1 (viral homologue of BCL2). The apoptotic effects were dependent on reactive oxygen species generation. Furthermore, SAHA/bortezomib suppressed the growth of Wp-restricted BL xenografts in nude mice. This study provides the rationale to test the novel application of SAHA/bortezomib on the treatment of EBV-associated Wp-restricted BL and post-transplant lymphoproliferative disorder.
Keywords: Burkitt lymphoma; Epstein-Barr virus; histone deacetylase inhibitor; lymphoblastoid cell lines; proteasome inhibitor.
© 2014 John Wiley & Sons Ltd.
Similar articles
-
Bortezomib induces apoptosis of Epstein-Barr virus (EBV)-transformed B cells and prolongs survival of mice inoculated with EBV-transformed B cells.J Virol. 2007 Sep;81(18):10029-36. doi: 10.1128/JVI.02241-06. Epub 2007 Jul 11. J Virol. 2007. PMID: 17626072 Free PMC article.
-
Tubacin kills Epstein-Barr virus (EBV)-Burkitt lymphoma cells by inducing reactive oxygen species and EBV lymphoblastoid cells by inducing apoptosis.J Biol Chem. 2009 Jun 19;284(25):17102-17109. doi: 10.1074/jbc.M809090200. Epub 2009 Apr 22. J Biol Chem. 2009. PMID: 19386607 Free PMC article.
-
Bortezomib and SAHA synergistically induce ROS-driven caspase-dependent apoptosis of nasopharyngeal carcinoma and block replication of Epstein-Barr virus.Mol Cancer Ther. 2013 May;12(5):747-58. doi: 10.1158/1535-7163.MCT-12-0811. Epub 2013 Mar 8. Mol Cancer Ther. 2013. PMID: 23475956
-
Antiproliferative and proapoptotic effects of proteasome inhibitors and their combination with histone deacetylase inhibitors on leukemia cells.Cardiovasc Hematol Disord Drug Targets. 2009 Mar;9(1):62-77. doi: 10.2174/187152909787581372. Cardiovasc Hematol Disord Drug Targets. 2009. PMID: 19275578 Review.
-
Therapeutic Strategies against Epstein-Barr Virus-Associated Cancers Using Proteasome Inhibitors.Viruses. 2017 Nov 21;9(11):352. doi: 10.3390/v9110352. Viruses. 2017. PMID: 29160853 Free PMC article. Review.
Cited by
-
The Dual Functions of Andrographolide in the Epstein-Barr Virus-Positive Head-and-Neck Cancer Cells: The Inhibition of Lytic Reactivation of the Epstein-Barr Virus and the Induction of Cell Death.Int J Mol Sci. 2023 Nov 1;24(21):15867. doi: 10.3390/ijms242115867. Int J Mol Sci. 2023. PMID: 37958849 Free PMC article.
-
Epstein-Barr Virus Promotes B Cell Lymphomas by Manipulating the Host Epigenetic Machinery.Cancers (Basel). 2020 Oct 19;12(10):3037. doi: 10.3390/cancers12103037. Cancers (Basel). 2020. PMID: 33086505 Free PMC article. Review.
-
Identification of Novel Small Organic Compounds with Diverse Structures for the Induction of Epstein-Barr Virus (EBV) Lytic Cycle in EBV-Positive Epithelial Malignancies.PLoS One. 2015 Dec 30;10(12):e0145994. doi: 10.1371/journal.pone.0145994. eCollection 2015. PLoS One. 2015. PMID: 26717578 Free PMC article.
-
Viral-Targeted Strategies Against EBV-Associated Lymphoproliferative Diseases.Front Oncol. 2019 Feb 26;9:81. doi: 10.3389/fonc.2019.00081. eCollection 2019. Front Oncol. 2019. PMID: 30873380 Free PMC article. Review.
-
Induction of MAPK- and ROS-dependent autophagy and apoptosis in gastric carcinoma by combination of romidepsin and bortezomib.Oncotarget. 2016 Jan 26;7(4):4454-67. doi: 10.18632/oncotarget.6601. Oncotarget. 2016. PMID: 26683357 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous